Correlation Between Armata Pharmaceuticals and Soligenix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Armata Pharmaceuticals and Soligenix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Armata Pharmaceuticals and Soligenix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Armata Pharmaceuticals and Soligenix, you can compare the effects of market volatilities on Armata Pharmaceuticals and Soligenix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Armata Pharmaceuticals with a short position of Soligenix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Armata Pharmaceuticals and Soligenix.

Diversification Opportunities for Armata Pharmaceuticals and Soligenix

0.25
  Correlation Coefficient

Modest diversification

The 3 months correlation between Armata and Soligenix is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Armata Pharmaceuticals and Soligenix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Soligenix and Armata Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Armata Pharmaceuticals are associated (or correlated) with Soligenix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Soligenix has no effect on the direction of Armata Pharmaceuticals i.e., Armata Pharmaceuticals and Soligenix go up and down completely randomly.

Pair Corralation between Armata Pharmaceuticals and Soligenix

Given the investment horizon of 90 days Armata Pharmaceuticals is expected to generate 2.7 times more return on investment than Soligenix. However, Armata Pharmaceuticals is 2.7 times more volatile than Soligenix. It trades about 0.02 of its potential returns per unit of risk. Soligenix is currently generating about -0.04 per unit of risk. If you would invest  225.00  in Armata Pharmaceuticals on September 11, 2024 and sell it today you would lose (3.00) from holding Armata Pharmaceuticals or give up 1.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Armata Pharmaceuticals  vs.  Soligenix

 Performance 
       Timeline  
Armata Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Armata Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable primary indicators, Armata Pharmaceuticals is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Soligenix 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Soligenix are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak technical and fundamental indicators, Soligenix may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Armata Pharmaceuticals and Soligenix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Armata Pharmaceuticals and Soligenix

The main advantage of trading using opposite Armata Pharmaceuticals and Soligenix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Armata Pharmaceuticals position performs unexpectedly, Soligenix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Soligenix will offset losses from the drop in Soligenix's long position.
The idea behind Armata Pharmaceuticals and Soligenix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Global Correlations
Find global opportunities by holding instruments from different markets